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Type A Insulin Resistance Syndrome is due to heterozygous mutations in the insulin receptor (INSR) 
gene or its signaling pathway.
We present a premenarcheal 14 year-old girl with normal BMI, severe hirsutism, acanthosis nigricans, 
clitoral hypertrophy, deep voice, enlarged polycystic ovaries, severe hyperinsulinemia and biochemical 
hyperandrogenism. 
We identifi ed a novel heterozygous missense variant in the tyrosine kinase domain of INSR 
(p.Leu1150Pro) and an heterozygous missense variant in SH2B adapter protein 1 involved in the insulin 
pathway (p.Ala663Val). Interestingly, the patients’ mother and brother had the same INSR mutation 
although of a milder phenotype, reason why their IR went undiagnosed. 
The novel heterozygous  p.Leu1150Pro mutation in the INSR gene appears to be the cause of the type 
A insulin resistance syndrome; the SH2B1 mutation, likely to synergistically affect the insulin pathway, 
may contribute to explain the more severe presentation of the phenotype in the patient and the phenotypic 
variability of the syndrome within this family.
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Insulin resistance (IR) generally occurs in obese individuals 
with a favorable genetic background; IR is rare in lean 
individuals. Most cases of this syndrome are due to mutations 
in the insulin receptor gene (INSR) or its signaling pathway 
[1,2]. Patients with Type A IR syndrome present severe IR, 
hyperandrogenism and acanthosis nigricans in the absence of 
obesity or lipoatrophy. Molecular studies help characterize this 
mostly monogenic condition.
Patient report
A 14 year-old caucasian girl consulted for hirsutism, 
acanthosis nigricans and absence of menarche despite thelarche 
start at age 9. She was born from non-consanguineous parents 
at term and with normal weight. Developmental milestones 
and her past medical history were normal; the patient´s health 
had been good and she had always had good appetite. No family 
history of diabetes was reported. 
Two years before admission the patient began to complain 
of progressive whole body and facial hirsutism associated to 
seborrhea and a deepening of her voice. Her height was 158.5 
cm (50th centile), weight 42.5 kg (10th centile) and BMI was 
14.3  kg/m2 (-1.3 SD). At physical examination she showed 
normal muscular habitus, severe hirsutism (Ferriman-Gallwey 
score=32) and acanthosis nigricans on the neck, axillae and 
knees (Figure 1), facial and capillary seborrhea, clitoromegaly 
and male like voice. Her breast staging was Tanner 4, her pubic 
hair 6 and bone age was 15 years. 
A trans-abdominal pelvic ultrasound showed a normal 
confi guration of the uterus. Both ovaries were enlarged with 
polycystic morphology (14.2 cm3 and 16.3 cm3) with normal 
adrenal glands; liver was also normal, without steatosis. 
Routine (glucose, hepatic and lipid profi le) and hormonal 
analyses at baseline and a standard 75-g oral glucose tolerance 
test (OGTT) were performed. Adrenal hyperfunction was ruled 
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out by ACTH test and suppression test with Dexamethasone. The 
patient showed severe biochemical ovarian hyperandrogenism, 
normal hepatic and lipid profi les and increased serum levels of 
adiponectin (Table 1A). OGTT showed fasting glucose level of 73 
mg/dL and 136 mg/dL at 120 min, with severe hyperinsulinemia 
(47.7 and 600 μUI/mL, respectively) (Table 1B).
After these molecular fi ndings, the family was evaluated. 
The mother (39 y-o) presented normal weight (BMI 23 kg/m2), 
her menarche had been at age 16, she had never been hirsute 
and had had no problems in conceiving. A mild acanthosis 
nigricans on the armpits was found at the physical exam. The 
father (38 y-p) was overweight (BMI 27.9 kg/m2) without 
any relevant fi ndings. The prepubertal brother (11.8 y-o) 
was overweight (BMI 25.5kg/m2) and presented acanthosis 
nigricans on the neck and hands. 
The mother and brother underwent similar baseline 
laboratory evaluations and OGTT; the father could not be 
evaluated due to social reasons. Hyperandrogenia (testosterone: 
87 ng/dl and androstenodione: 441 ng/dL) and severe 
hyperinsulinemia were found in the mother, without changes 
in the glucose responses to the OGTT. Severe hyperinsulinism 
was found for the brother at OGTT (Table 1B) although with 
normal glucose responses. His androgenic profi le was normal. 
With the diagnosis of Type A IR syndrome, the patient was 
started on Metformin 1500 mg/day. Her menarche occurred 3 
months later. She was lost to follow up due to social reasons. 
Molecular study
Genomic DNA was isolated from peripheral blood by 
CTAB method [3]. The patient´s clinical exome was studied 
by next generation sequencing (NGS) using the TruSight One 
assay in a NextSeq500 system Illumina. Resulting variants 
were prioritized, considering mutation impact, population 
frequency, and a list of candidate genes according to the 
pathway suspected to be altered (list of genes available upon 
request). The variants identifi ed were confi rmed in the patient 
and her relatives by PCR amplifi cation and Sanger sequencing 
to evaluate its segregation (primers available upon request).
In silico bioinformatic analysis: Missense variants on 
candidate genes identifi ed by NGS sequencing were classifi ed 
based on their potential impact on protein function or structure 
using fi ve in silico bioinformatics tools (Polyphen-2, Mutation 
Taster, SIFT, MutPred, and CADD prediction). Sequence 
variants were classifi ed according to ACMG guidelines [4].
A novel heterozygous missense variant in exon 19 of INSR 
gene (NM_000208.3: c.3449T>C, p.Leu1150Pro) was identifi ed 
in the proband. This variant is in the tyrosine kinase domain of 
the insulin receptor. Sanger sequencing confi rmed the fi ndings 
in the patient and revealed that her mother and her brother 
were heterozygous for the same variant.
The variant found in the INSR gene is classifi ed as likely 
pathogenic according to ACMG guidelines. This mutation has 
not been reported in publicly available 1000G, ExAC, EVS and 
NCBI dbSNP databases and was predicted to be pathogenic by 
fi ve in silico bioinformatics tools. By the multiple alignment 
analysis of the insulin receptor sequences in several species, 
we found that Leu1150 was conserved http://www.ibi.vu.nl/
programs/pralinewww/(Supplementary Figure 1). Introduction 
of proline in position 1150 is predicted to have helix-
breaking effects according to PSIPRED [5]. Furthermore, in 




Figure 1: Severe hirsutism (Ferriman-Gallwey score of 32) and acanthosis 
nigricans on the neck, axillae and knees.
Table 1: Laboratory evaluations in the patient, her mother and brother, all affected 
with the same insuline receptor mutation.
A. Initial investigations in the patient Patient Normal range  
Total testosterone (ng/dL) 128 10-50
 
Androstenodione (ng/dL) 995 80-250
DHEA-S (ng/mL) 2500 600-2880
17 OH-Progesterone (ng/mL)   
Baseline 2 ≤ 2
60 min 2.8 ≤ 10
SHBG (nmol/L) 24 40-80
LH (IU/L) 7.6 0.4-1.2
FSH (IU/L) 3.5 1.3-10.8
Estradiol (pg/mL) 35 20-200
TSH (μIU/mL) 1.6 0.5-6.5
Free T4 (ng/dL) 0.98 0.8-2
Prolactin (ng/mL) 13 3-25
AST (U/L) 11 5-33
ALT (U/L) 17 5-32
Total bilirubin (mg/dL) 0.62 0.1-1.1
Total cholesterol (mg/dL) 147 110-181
Triglycerides (mg/dL) 60 31-119
HDL-C (mg/dL) 66 35-82
LDL-C (mg/dL) 69 59-145
HbA 1 C (%) 4.7 <6
Adiponectin (mg/L) 13.4 5.2 - 11.8
B: OGTT in the patient and her family 
members
Patient Mother Brother
Glucose baseline (mg/dL) 73 85 88.9
Glucose at 120 min (mg/dL) 136 84.7 114
Insulin baseline (μIU/mL) 47.7 41.2 35.3
Maximum Insulin (μIU/mL) 600 300 313.2
HOMA 8.6 8.6 7.7
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Proline 1150 breaks the alpha-helix E and changes the bonding 
angle of the polypeptide chain, yielding a helix distortion 
(Supplementary Figure 2). This amino acid change could alter 
the displacement from the catalytic site of the activation loop, 
therefore probably causing loss of kinase activity. 
In the proband, exome analysis also revealed a 
heterozygous missense variant in exon 11 of SH2B1 gene 
(NM_0011457951:c.1988C>T, p.Ala663Val). This variant was 
paternally-inherited. SH2B1 gene encodes an adaptor protein 
(SH2-B) that is involved in the insulin pathway. 
The variant found in SH2B1 gene is classifi ed as a variant 
of unknown signifi cance according to ACMG guidelines. It has 
a population frequency lower than 1% in ExAC and 1000G. The 
potential effect of this variant on protein function has variable 
classifi cation from benign (Polyphen-2 and Mutation Taster) 
or tolerated (SIFT) to potential high impact (CADD score=2.5). 
Discussion
We describe a premenarcheal patient that presented 
with severe hyperandrogenism, acanthosis nigricans and 
severe IR. Although the criteria of severe IR in OGTT is not 
formally established, a peak insulin higher than 260 μUI/mL 
in individuals with BMI < 30 kg/m is the value considered 
in practice [1,2]. The patient was diagnosed as a classical 
phenotype of the Type A IR syndrome (OMIM # 610549*).
One of the differential diagnosis of this syndrome is the 
polycystic ovarian syndrome. The pelvic ultrasound showed 
a very important enlargement of both ovaries with polycystic 
morphology. The natural history of Type A IR syndrome in 
a cohort followed for up to 30 years showed that 6 out of 8 
female patients needed surgical intervention to control the 
hyperandrogenism including partial or total removal of the 
ovaries due to massive ovarian enlargement [6]. However, 
the pathophysiological mechanisms of hyperinsulinemia 
within the ovaries and other tissues when insulin receptor is 
defective remain unexplained. It is well established that the 
insulin receptor and the IGF1 receptor (IGF1R) act through 
similar post-receptor pathways. High insulin concentrations 
can cross-react with the IGF1R or IGF1R–IR hybrid receptors 
promoting the clinical and biochemical manifestations of the 
syndrome [7]. According to the results of the largest cohort 
study of this rare condition, hyperinsulinemia correlates with 
the degree of hyperandrogenism, ovarian enlargement [6] and 
the degree of acanthosis nigricans [8]. The pathogenesis of 
this skin disorder is not completely clear; it has been proposed 
that high levels of insulin activate IGF1R to increase the mitotic 
activity of keratinocytes causing darkening and thickening in 
folds such as neck, armpit, and extension areas such as knees 
and fi ngers knuckles [8]. 
Our patient´s laboratory results support the absence of fatty 
liver and show a normal lipid profi le. This is an element of 
differential diagnosis with lipodystrophy where the patients 
showed severe dyslipidemia [9]. Interestingly, the patient 
showed increased serum levels of adiponectin. This fi nding 
is usually described in patients with severe IR due to receptor 
defects in contrast to prevalent forms of IR associated with 
obesity where adiponectin levels are reduced. Hyperinsulinemia 
is able to suppress the adiponectin gene expression in adipose 
tissue if the elements of the cellular insulin signal network are 
intact [10]. 
Although no functional data were reported for the variant 
identifi ed in this family, we assume that it is likely to be 
causal of the severe IR for several reasons. The Leu1150 residue 
affects the tyrosine kinase activity and functional studies have 
shown that mutations in tyrosine kinase domain impair insulin 
action [11,12], this very rare variant is absent from the controls 
provided by public databases including the ExAC browser 
covering the exomes of > 65,000 individuals. Furthermore, 
the variant shows co-segregation with disease in the affected 
family members.
Defects in the INSR gene cause a wide spectrum of congenital 
diseases associated with IR. In contrast with biallelic mutations 
of INSR that result in the more severe Donohue syndrome 
or Rabson–Mendenhall syndrome, Type A IR syndrome is 
typically due to heterozygous mutations in the INSR gene 
with autosomal dominant pattern of inheritance. The clinical 
manifestation is related to a dominant-negative mechanism 
that has been proposed in other mutations affecting the 
tyrosine kinase activity of the insulin receptor [13]. Mutants 
and wild type heterodimers of insulin receptor associated 
randomly might lead to a 75% reduction in insulin receptor 
tyrosine kinase activity [8]. 
Sexual dimorphism is associated with type A IR syndrome, 
which is more often diagnosed in females during infancy 
or adolescence than in males, since females show more 
health problems associated with this condition (especially 
hyperandrogenism) while males only present acanthosis 
nigricans, symptomatic postprandial hypoglycemia and 
commonly go undiagnosed, or simply diagnosed with “type 
2 diabetes” in mid-life [1]. In the case of this family, if the 
proband had not been diagnosed, the patient’s brother would 
probably have gone undiagnosed.
Our patient presented more severe phenotype than 
her mother, who had had no clinical manifestations of 
hyperandrogenism during adolescence and nowadays only 
shows a mild acanthosis nigricans. We assume that the 
phenotypical differences could be explained by the coexistence 
of two variants in different genes of the insulin pathway. 
The insulin pathway, in our patient, would sinergically 
have been affected by the INSR mutation and the SH2B1 gene 
variant found. SH2B adapter protein 1 adaptor binds to the 
activation loop of IR via its SH2 domain. It is functionally a 
physiological enhancer of insulin action required for glucose 
homeostasis. The systemic deletion of SH2B1 impaired the 
insulin receptor activation. SH2B1-/- knockout mice developed 
hyperinsulinemia and glucose intolerance and their insulin 
levels were 20-fold higher than normal while blood glucose 
levels were 3.3-fold above those of age-matched wild-type 
controls [14]. 
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In our patient, the additional variant may translate into a 
more severe phenotype, compared to her mother who only had 
the insulin gene variant defect but did not present hirsutism 
during adolescence. 
Conclusion
We identifi ed a novel heterozygous mutation (p.Leu1150Pro) 
in the INSR gene using an NGS approach in an adolescent with 
Type A IR syndrome. The fi nding of other variant of the SH2B1 
gene, likely to synergistically affect the insulin pathway, may 
contribute to explain the more severe presentation of the 
phenotype in the patient and the phenotypic variability of the 
syndrome within this family.
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